Medicare Enrolled

Dr. Stephen Bernstein, M.D.

Rheumatology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1041 3RD AVE STE 201, New York, NY 10065
2125353222
In practice since 2006 (19 years)
NPI: 1215017736 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bernstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bernstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bernstein

Dr. Stephen Bernstein is a rheumatology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bernstein performed 5,801 Medicare services across 845 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bernstein received a total of $204,127 from 58 pharmaceutical and/or device companies across 1417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bernstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 23% volume in NY $204,127 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,801
Medicare services
Top 23% in NY for rheumatology
845
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~305 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hyaluronan intra-articular injection, 1 mg
An injection of hyaluronan or its derivative into a joint space. This procedure delivers 1 mg of the substance directly into the affected joint.
1,941 $8 $19
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
853 $103 $154
Methotrexate sodium, 5 mg 844 $0 $9
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
627 $4 $5
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
385 $66 $113
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
219 $91 $153
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
177 $66 $96
Limited ultrasound of joint or extremity
A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels.
170 $38 $108
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
163 $59 $87
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
150 $3 $3
Complete ultrasound scan of joint
An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures.
74 $48 $89
Ultrasound-guided joint aspiration or injection
Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement.
38 $78 $117
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
36 $13 $20
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
32 $60 $83
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $33 $97
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
20 $50 $84
Tuberculosis skin test
A small amount of fluid is injected under the skin to check for a reaction that indicates exposure to tuberculosis bacteria.
19 $9 $14
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
15 $1 $21
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
14 $13 $17
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
60.0% medium
39.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$204,127
Total received (2018-2024)
Avg $29,161/year across 7 years
Top 4% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,417
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$177,009 (86.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,893 (11.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,225 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$35,689
2023
$27,450
2022
$28,244
2021
$12,428
2020
$18,170
2019
$51,398
2018
$30,748

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$22,048
Mallinckrodt Hospital Products Inc.
$10,572
Amgen Inc.
$979
AstraZeneca Pharmaceuticals LP
$796
PFIZER INC.
$247
UCB, Inc.
$225
GlaxoSmithKline, LLC.
$165
Janssen Scientific Affairs, LLC
$141
Novartis Pharmaceuticals Corporation
$136
Lilly USA, LLC
$112
E.R. Squibb & Sons, L.L.C.
$58
Genentech USA, Inc.
$53
Novo Nordisk Inc
$40
Kiniksa Pharmaceuticals International, plc
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$19
Hikma Pharmaceuticals USA
$13
Janssen Biotech, Inc.
$2
Top 3 companies account for 94.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$38,758
Mallinckrodt Hospital Products Inc.
$38,219
Mallinckrodt Enterprises LLC
$31,395
AbbVie Inc.
$29,646
AbbVie, Inc.
$19,668
Mallinckrodt LLC
$19,323
Amgen Inc.
$4,057
Eli Lilly and Company
$2,475
PFIZER INC.
$2,170
AstraZeneca Pharmaceuticals LP
$1,774
UCB, Inc.
$1,697
Novo Nordisk Inc
$1,388
Lilly USA, LLC
$1,372
GlaxoSmithKline, LLC.
$1,349
Novartis Pharmaceuticals Corporation
$1,210
Regeneron Healthcare Solutions, Inc.
$1,193
IBSA Pharma Inc.
$750
Flexion Therapeutics, Inc.
$561
Janssen Biotech, Inc.
$555
Horizon Therapeutics plc
$554
E.R. Squibb & Sons, L.L.C.
$506
Celgene Corporation
$466
Horizon Pharma plc
$451
Genentech USA, Inc.
$344
SANOFI-AVENTIS U.S. LLC
$302
Takeda Pharmaceuticals U.S.A., Inc.
$300
Biohaven Pharmaceuticals, Inc.
$295
IDORSIA PHARMACEUTICALS US INC
$266
Janssen Scientific Affairs, LLC
$259
Antares Pharma, Inc.
$258
Radius Health, Inc.
$242
Boehringer Ingelheim Pharmaceuticals, Inc.
$223
Biohaven Pharmaceutical Holding Company Ltd.
$209
Allergan Inc.
$177
Kowa Pharmaceuticals America, Inc.
$164
GENZYME CORPORATION
$161
Gilead Sciences, Inc.
$151
Merck Sharp & Dohme Corporation
$146
Bayer HealthCare Pharmaceuticals Inc.
$127
MEDAC PHARMA, INC.
$127
Daiichi Sankyo Inc.
$125
Regeneron Pharmaceuticals, Inc.
$119
DePuy Synthes Sales Inc.
$107
Alexion Pharmaceuticals, Inc.
$72
Exeltis, USA Inc.
$67
Teva Pharmaceuticals USA, Inc.
$50
Kiniksa Pharmaceuticals International, plc
$39
Hikma Pharmaceuticals USA
$33
Otsuka America Pharmaceutical, Inc.
$33
Purdue Pharma L.P.
$28
West-Ward Pharmaceuticals
$27
Sandoz Inc.
$27
Allergan, Inc.
$26
Supernus Pharmaceuticals, Inc.
$20
Esperion Therapeutics, Inc.
$18
Avion Pharmaceuticals
$17
Oxford Immunotec USA Inc
$16
MEDEXUS PHARMA, INC.
$14
Top 3 companies account for 53.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AIRSUPRA · AJOVY · Actemra · Aimovig · Arcalyst · BENLYSTA · BREZTRI · BYDUREON · Bimzelx · CHANTIX · COMIRNATY · COSENTYX · CREON · CYLTEZO · Cimzia · ELIQUIS · ENTRESTO · EVENITY · Enbrel · Entyvio · Epclusa · FARXIGA · HUMIRA · HYRIMOZ · Humira · JANUVIA · JARDIANCE · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kerendia · Kloxxado · LINZESS · LYRICA · Licart · Livalo · MOVANTIK · Mitigare · Movantik · NEXLETOL · NOCDURNA · NP Thyroid 60 · NURTEC ODT · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · Ozempic · PRALUENT · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · RAYOS · REMICADE · REXULTI · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STEGLATRO · STELARA · STRENSIQ · SYMPROIC · SYNTHROID · SYNVISC-ONE · Strensiq · T-SPOT.TB8 · TALTZ · TAVNEOS · TLANDO · TOVIAZ · TRELEGY ELLIPTA · TREMFYA · TRINTELLIX · TRULICITY · Tavneos · Trintellix · Tymlos · UBRELVY · Uloric · VIBERZI · XELJANZ · XYOSTED · Xofluza · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for rheumatology in NY.

Looking for a rheumatology specialist in New York?
Compare rheumatologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
383
Per 100K population
23.5
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bernstein is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NY), with speaking/promotional industry engagement in the top 4% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bernstein experienced with hyaluronan intra-articular injection, 1 mg?
Based on Medicare claims data, Dr. Bernstein performed 1,941 hyaluronan intra-articular injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bernstein receive payments from pharmaceutical companies?
Yes. Dr. Bernstein received a total of $204,127 from 58 companies across 1,417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bernstein's costs compare to other rheumatologists in New York?
Dr. Bernstein's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bernstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →